MedPath
HSA Approval

Rosmi 10 Film-Coated Tablets 10mg

SIN17116P

Rosmi 10 Film-Coated Tablets 10mg

Rosmi 10 Film-Coated Tablets 10mg

October 17, 2024

UNI DRUG HOUSE

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantUNI DRUG HOUSE

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

C10AA07

Manufacturer Information

UNI DRUG HOUSE SDN. BHD.

Cadila Pharmaceuticals Limited

Active Ingredients

Rosuvastatin Calcium eqv. Rosuvastatin

10mg

Rosuvastatin

Documents

Package Inserts

Rosmi Tablet PI.pdf

Approved: October 17, 2024

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Rosmi 10 Film-Coated Tablets 10mg - HSA Approval | MedPath